Skip to main content
. 2024 May 24;8:119. doi: 10.1038/s41698-024-00603-z

Table 1.

Late onset CMMRD patients with first cancer diagnosis at age ≥ 25 years

Publication Patient ID Gene (Transcript ID) Variant 1 Variant 2 Cancer Diagnoses (age in years) - Molecular Pathology Other Clinical Features (age in years)
Present study Case 1

MSH6

(NM_000197.3)

c.3226C>T

p.(Arg1076Cys)

missense

c.3226C>T

p.(Arg1076Cys)

missense

OC (27)

EC (27)

OC relapse (31)

CRC (43) - absent MSH6 expression, MSI-high

CRC (52) - irregular MSH6 expression

GBM (56) - IDH-WT, MSS, TMB 368mut/Mb, POLE variants

Duodenal and colorectal adenomas and polyps (39 + )

Duodenal adenoma (53) - irregular MSH6 expression, MSS

LS family history

Case 2

MLH1

(NM_000249.4)

c.306G>A a

p.[(Lys70_Glu102del,Glu102=)]

loss of 33 AA, silent

c.306G>A a

p.[(Lys70_Glu102del,Glu102=)]

loss of 33 AA, silent

EC (38) - present MMR expression, MSI-high

Three colonic adenomas (39)

Three affected siblings with either GC (35), BT (30), or GIC (35)

Gardès et al. 38 P3

MSH6

(NM_000197.3)

c.3226C>T

p.(Arg1076Cys)

missense

c.3226C>T

p.(Arg1076Cys)

missense

CRC (45)

CRC (49)

Colorectal polyps (age not reported)
Lavoine et al. 39 11(15)

PMS2

(NM_000535.7)

c.2531C>A

p.(Pro844His)

missense

c.2531C>A

p.(Pro844His)

missense

CRC (33) - MSI-high

CRC (46)b

Two colonic adenomas (33)

Sibling with CRC (20), GC (32), and GBM (32)

Li et al. 40 c III-3

PMS2

(NM_000535.7)

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

CRC (26) - absent PMS2 expression

DC (40)

Gastrointestinal polyps (age not reported)

LS family history

CALM

Absent PMS2 expression in normal tissue

NA

PMS2

(NM_000535.7)

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

CRC (38) None reported
NA

PMS2

(NM_000535.7)

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

CRC (31) None reported
NA

PMS2

(NM_000535.7)

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

c.2002A>G a

p.[(Ile668*,Ile668Val)]

truncating, missense

CRC (31) None reported
Shuen et al. 41 MMR108

PMS2

(NM_000535.7)

c.2531C>A

p.(Pro844His)

missense

c.1261C>T

p.(Arg421*)

truncating

CRC (27)

CRC (27)

Four colorectal adenomas (27)

Absent PMS2 expression in normal tissue

MMR120

MSH6

(NM_000197.3)

c.3226C>T

p.(Arg1076Cys)

missense

c.1421_1422dupTG

p.(Gln475Glyfs*7)

truncating

GBM (27)

GBM relapse (28)

None reported
MMR189

PMS2

(NM_000535.7)

c.137G>T

p.(Ser46Ile)

missense

c.137G>T

p.(Ser46Ile)

missense

CRC (28)

CRC (32)

M (45)

BC (49)

CRC (50)

CRC (52)

PrC (53)

Absent PMS2 expression in normal tissue
Xie et al. 42 III.1

MSH6

(NM_000197.3)

c.3226C>T

p.(Arg1076Cys)

missense

c.3226C>T

p.(Arg1076Cys)

missense

CRC (32) - subclonal absent MSH6 expression, MSS, TMB-high

CRC relapse (34)

Neurofibromas (unknown)

Fourth degree consanguineous parents

LS family history

CALM

Bruekner et al. 43 NA

MSH2

(NM_000251.3)

c.188T>A

p.(Val63Glu)

missense

c.188T>A

p.(Val63Glu)

missense

CRC (25) Two siblings with CRC (17 and 26)

AA amino acid, CALM cafe au lait macule, CMMRD constitutional mismatch repair deficiency, LS Lynch syndrome, MSI microsatellite instability, MSS microsatellite stable, TMB tumour mutation burden, BC bladder cancer, BT brain tumour (unknown classification), CRC colorectal cancer, DC duodenal cancer, EC endometrial cancer, GBM glioblastoma (astrocytoma), GC gastric cancer, GIC gastrointestinal cancer (unknown location), HGG high grade glioma (including primitive neuroectodermal tumour), IC intestinal cancer (assumed jenunal or ileal), M melanoma, OC ovarian cancer, PrC prostate cancer.

aThe variant causes a “leaky” splice effect.

bA rectal cancer diagnosed at age 46 years was previously unreported.

c Also see Biswas et al.45 for functional analyses of PMS2 c.2002A>G.